Significant association between tumor mutational burden and immune-related adverse events during immune checkpoint inhibition therapies Csaba KerepesiTibor BakacsColin C. Anderson Commentary Open access 09 March 2020 Pages: 683 - 687
Association of cancer progression with elevated expression of programmed cell death protein 1 ligand 1 by upper tract urothelial carcinoma and increased tumor-infiltrating lymphocyte density Akinori NukuiTakao KamaiKen-Ichiro Yoshida Original Article Open access 06 February 2020 Pages: 689 - 702
The fully synthetic glycopeptide MAG-Tn3 therapeutic vaccine induces tumor-specific cytotoxic antibodies in breast cancer patients Pierre RosenbaumCécile ArtaudClaude Leclerc Original Article 07 February 2020 Pages: 703 - 716
Age-associated changes in the immune system may influence the response to anti-PD1 therapy in metastatic melanoma patients Henna KasanenMicaela HernbergAnna Kreutzman Original Article Open access 08 February 2020 Pages: 717 - 730
Nonlinear response to cancer nanotherapy due to macrophage interactions revealed by mathematical modeling and evaluated in a murine model via CRISPR-modulated macrophage polarization Fransisca LeonardLouis T. CurtisHermann B. Frieboes Original Article 08 February 2020 Pages: 731 - 744
Activation of TLR4 signaling inhibits progression of osteosarcoma by stimulating CD8-positive cytotoxic lymphocytes Kenichiro YahiroYoshihiro MatsumotoYasuharu Nakashima Original Article 11 February 2020 Pages: 745 - 758
Talimogene laherparepvec treatment to overcome loco-regional acquired resistance to immune checkpoint blockade in tumor stage IIIB–IV M1c melanoma patients Anne FröhlichDennis NiebelJennifer Landsberg Original Article Open access 12 February 2020 Pages: 759 - 769
Tumor mutational load, CD8+ T cells, expression of PD-L1 and HLA class I to guide immunotherapy decisions in NSCLC patients Daan P. HurkmansMerian E. KuipersSjoerd H. van der Burg Original Article Open access 12 February 2020 Pages: 771 - 777
Human inflammatory dendritic cells in malignant pleural effusions induce Th1 cell differentiation Fei-fei GuJing-jing WuLi Liu Original Article Open access 12 February 2020 Pages: 779 - 788
CD160 expression on CD8+ T cells is associated with active effector responses but limited activation potential in pancreatic cancer Songyang LiuWei ZhangYingchao Wang Original Article 13 February 2020 Pages: 789 - 797
Co-expression of HLA-I loci improved prognostication in HER2+ breast cancers Julia Y. TsangChun-Sing HoGary M. Tse Original Article 13 February 2020 Pages: 799 - 811
Immunoregulatory effects of Lurbinectedin in chronic lymphocytic leukemia Denise RisnikAna ColadoMirta Giordano Original Article 13 February 2020 Pages: 813 - 824
CIK cell cytotoxicity is a predictive biomarker for CIK cell immunotherapy in postoperative patients with hepatocellular carcinoma Qiu-Zhong PanQing LiuJian-Chuan Xia Original Article 14 February 2020 Pages: 825 - 834
LincRNA-p21 knockdown reversed tumor-associated macrophages function by promoting MDM2 to antagonize* p53 activation and alleviate breast cancer development Lining ZhouYu TianZhaoliang Su Original Article 15 February 2020 Pages: 835 - 846
Mixed 20-peptide cancer vaccine in combination with docetaxel and dexamethasone for castration-resistant prostate cancer: a randomized phase II trial Masanori NoguchiGaku AraiKyogo Itoh Clinical Trial Report Open access 05 February 2020 Pages: 847 - 857
Long-term surviving cancer patients as a source of therapeutic TCR Else Marit InderbergSébastien Wälchli Focussed Research Review Open access 08 January 2020 Pages: 859 - 865
New targets for therapy: antigen identification in adults with B-cell acute lymphoblastic leukaemia Stephanie JordaensLeah CookseyBarbara-ann Guinn Focussed Research Review Open access 22 January 2020 Pages: 867 - 877
Current progress in NK cell biology and NK cell-based cancer immunotherapy Raquel TarazonaNelson Lopez-SejasRafael Solana Focussed Research Review 04 March 2020 Pages: 879 - 899
“Tumor immunology meets oncology (TIMO) XV”, April 25th–27th 2019, Halle/Saale, Germany André StevenChiara MassaBarbara Seliger Meeting Report Open access 05 February 2020 Pages: 901 - 909
